Michael Amlung1, James MacKillop1,2,3, Peter M Monti3, Robert Miranda3. 1. Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton,Ontario, Canada. 2. Homewood Research Institute, Homewood Health Centre, Guelph, Ontario, Canada. 3. Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island.
Abstract
OBJECTIVE: Cigarette smokers are more likely to consume alcohol at higher levels and experience poorer response to treatment for alcohol problems than are nonsmokers. One previous study in university students suggests that a potential reason for the high overlap between alcohol and tobacco use is that concurrent smoking is associated with overvaluation of alcohol, as reflected in elevated behavioral economic demand. The present study sought to extend these initial findings in a community sample with heavier levels of alcohol and tobacco use. METHOD: Participants were 111 non-treatment-seeking heavy drinkers(defined as 18+/14+ drinks per week for men/women) from a larger study on alcohol pharmacotherapy mechanisms. Forty-nine participants (44%) reported regular smoking (≥5 cigarettes/day). Participants completed a hypothetical alcohol purchase task assessing alcohol consumption at escalating levels of price. Covariates included demographics, drinking quantity, alcohol use disorder severity, depression, and delay discounting. RESULTS: In covariate-adjusted models, smokers reported significantly higher maximum alcohol expenditures (Omax) and breakpoint price (first price suppressing consumption to zero) compared with nonsmokers. Elevated alcohol demand correlated with drinking quantity and severity in the entire sample, but not with smoking frequency or nicotine dependence among smokers only. CONCLUSIONS: This study offers further evidence of increased reinforcing value of alcohol among smokers in a sample of heavy drinkers from the community. Clinical implications and potential mechanisms underlying this relationship are discussed.
OBJECTIVE: Cigarette smokers are more likely to consume alcohol at higher levels and experience poorer response to treatment for alcohol problems than are nonsmokers. One previous study in university students suggests that a potential reason for the high overlap between alcohol and tobacco use is that concurrent smoking is associated with overvaluation of alcohol, as reflected in elevated behavioral economic demand. The present study sought to extend these initial findings in a community sample with heavier levels of alcohol and tobacco use. METHOD:Participants were 111 non-treatment-seeking heavy drinkers(defined as 18+/14+ drinks per week for men/women) from a larger study on alcohol pharmacotherapy mechanisms. Forty-nine participants (44%) reported regular smoking (≥5 cigarettes/day). Participants completed a hypothetical alcohol purchase task assessing alcohol consumption at escalating levels of price. Covariates included demographics, drinking quantity, alcohol use disorder severity, depression, and delay discounting. RESULTS: In covariate-adjusted models, smokers reported significantly higher maximum alcohol expenditures (Omax) and breakpoint price (first price suppressing consumption to zero) compared with nonsmokers. Elevated alcohol demand correlated with drinking quantity and severity in the entire sample, but not with smoking frequency or nicotine dependence among smokers only. CONCLUSIONS: This study offers further evidence of increased reinforcing value of alcohol among smokers in a sample of heavy drinkers from the community. Clinical implications and potential mechanisms underlying this relationship are discussed.
Authors: Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering Journal: Psychopharmacology (Berl) Date: 2006-10-18 Impact factor: 4.530
Authors: Michael T Amlung; John Acker; Monika K Stojek; James G Murphy; James MacKillop Journal: Alcohol Clin Exp Res Date: 2011-10-21 Impact factor: 3.455
Authors: Ali M Yurasek; James G Murphy; Ashley Hum Clawson; Ashley A Dennhardt; James MacKillop Journal: J Stud Alcohol Drugs Date: 2013-07 Impact factor: 2.582
Authors: Vanessa Morris; Herry Patel; Lana Vedelago; Derek D Reed; Jane Metrik; Elizabeth Aston; James MacKillop; Michael Amlung Journal: J Stud Alcohol Drugs Date: 2018-11 Impact factor: 2.582
Authors: Ivori Zvorsky; Tyler D Nighbor; Allison N Kurti; Michael DeSarno; Gideon Naudé; Derek D Reed; Stephen T Higgins Journal: Prev Med Date: 2019-08-07 Impact factor: 4.018
Authors: Martin Henry Plawecki; Kurt White; Ann E K Kosobud; Nicholas Grahame; Ulrich S Zimmermann; David Crabb; Sean O'Connor Journal: Alcohol Clin Exp Res Date: 2018-08-29 Impact factor: 3.455
Authors: Victor Martínez-Loredo; Alba González-Roz; Roberto Secades-Villa; José R Fernández-Hermida; James MacKillop Journal: Addiction Date: 2021-01-15 Impact factor: 7.256
Authors: ReJoyce Green; James MacKillop; Emily E Hartwell; Aaron C Lim; Wave-Ananda Baskerville; Mitchell Karno; Lara A Ray Journal: Nicotine Tob Res Date: 2021-03-19 Impact factor: 5.825
Authors: Yong Cui; Paulina Linares Abrego; Jin Ho Yoon; Maher Karam-Hage; Paul M Cinciripini; Nassima Ait-Daoud Tiouririne; Robert M Anthenelli; Jason D Robinson Journal: Front Psychiatry Date: 2021-06-23 Impact factor: 4.157